ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Osteoarthritis |
M15-M19, M47 |
PTGS1 |
G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
PTGS1 |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
PTGS1 |
K00-K95: Diseases of the digestive system |
Ulcerative colitis |
K51 |
PTGS1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
PTPN1; PTPN1; GPBAR1 |
A00-B99: Certain infectious and parasitic diseases |
Leishmaniasis |
B55.0 |
PLA2G1B |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Nerve injury |
T14.4 |
PLA2G1B |
A00-B99: Certain infectious and parasitic diseases |
Visceral leishmaniasis |
B55.0 |
PLA2G1B |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses |
L20-L30 |
PLA2G1B |
K00-K95: Diseases of the digestive system |
Inflammatory bowel disease |
K50, K51 |
PTGS1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
PTPN1 |
N00-N99: Diseases of the genitourinary system |
Dysmenorrhea |
N94.4-N94.6 |
PTGS1 |
C00-D49: Neoplasms |
Head and neck cancer |
C07-C14, C32-C33 |
AKR1B1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Acne vulgaris |
L70.0 |
PTGS1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Pruritus |
L29 |
PLA2G1B |
I00-I99: Diseases of the circulatory system |
Arteriosclerosis |
I70 |
PLA2G1B |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
GPBAR1 |
NA: NA |
Rheumatold arthritis |
NA |
PTGS1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Gout |
M10 |
AKR1B1 |
H00-H59: Diseases of the eye and adnexa |
Glaucoma |
H40-H42 |
AKR1B1 |
NA: NA |
Colour dead tissues |
NA |
PTPN1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
PTPN1; AKR1B1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Dermatitis |
L20-L30 |
PTGS1 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Postoperative inflammation |
T81 |
PTGS1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Contact dermatitis |
L23, L24, L25 |
PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic complication |
E08-E13 |
AKR1B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic cataract |
E10.36, E11.36 |
AKR1B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
PTGS1; AKR1B1 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
CDC25B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Dietary shortage |
E40-E46 |
PTGS1 |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
NA: NA |
Miosis during ocular surgery |
NA |
PTGS1 |
C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
PTGS1; PLA2G1B |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp |
L20-L30 |
PLA2G1B |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Arthritis |
M00-M25 |
PLA2G1B |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
PLA2G1B; AKR1B1 |
A00-B99: Certain infectious and parasitic diseases |
Infections |
A00-B99 |
PTPN1 |
C00-D49: Neoplasms |
Colorectal cancer |
C18-C21 |
PTGS1 |
J00-J99: Diseases of the respiratory system |
Allergic rhinitis |
J00, J30, J31.0, T78.4 |
PLA2G1B |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Allergy |
T78.4 |
PLA2G1B |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
CYP3A4 |